| Literature DB >> 27111894 |
Elaine C Lee1,2, Heejung Kim1, Jennifer Ditano1, Dacie Manion1, Benjamin L King1, Kevin Strange1.
Abstract
Protein function is controlled by the cellular proteostasis network. Proteostasis is energetically costly and those costs must be balanced with the energy needs of other physiological functions. Hypertonic stress causes widespread protein damage in C. elegans. Suppression and management of protein damage is essential for optimal survival under hypertonic conditions. ASH chemosensory neurons allow C. elegans to detect and avoid strongly hypertonic environments. We demonstrate that mutations in osm-9 and osm-12 that disrupt ASH mediated hypertonic avoidance behavior or genetic ablation of ASH neurons are associated with enhanced survival during hypertonic stress. Improved survival is not due to altered systemic volume homeostasis or organic osmolyte accumulation. Instead, we find that osm-9(ok1677) mutant and osm-9(RNAi) worms exhibit reductions in hypertonicity induced protein damage in non-neuronal cells suggesting that enhanced proteostasis capacity may account for improved hypertonic stress resistance in worms with defects in osmotic avoidance behavior. RNA-seq analysis revealed that genes that play roles in managing protein damage are upregulated in osm-9(ok1677) worms. Our findings are consistent with a growing body of work demonstrating that intercellular communication between neuronal and non-neuronal cells plays a critical role in integrating cellular stress resistance with other organismal physiological demands and associated energy costs.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27111894 PMCID: PMC4844114 DOI: 10.1371/journal.pone.0154156
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Effect of osm-9 and osm-12 mutations and genetic ablation of ASH osmosensory neurons on survival during hypertonic stress.
(A) Survival of wild type worms and osm-9(ky10) loss-of-function mutants exposed to different concentrations of NaCl for 24 h. Values are means ± S.E. of four independent and blinded experiments. *P<0.05 and **P<0.001 compared to wild type animals. (B) Survival of wild type worms and osm-9(ok1677) and osm-12(n1606) loss-of-function mutants exposed to different concentrations of NaCl for 24 h. Values are means ± S.E. of four independent experiments. *P<0.05 for both osm-9(ok1677) and osm-12(n1606) mutants compared to wild type animals. (C) Survival of wild type and ASH ablated (i.e., Is[sra-6p::mCasp1] transgenic strain) worms exposed to 500 or 600 mM NaCl for 24 h. Values are means ± S.E. of 6–12 independent experiments. *P<0.002 and **P<0.02 compared to wild type worms. (D) Survival of wild type, gpa-4(pk381) mutants and ASI ablated (i.e., oyIs84[gpa-4p::TU#813 + gcy-27p::TU#814 + gcy-27p::GFP + unc-122p::dsRed] transgenic strain) worms exposed to 500 or 600 mM NaCl for 24 h. Values are means ± S.E. of 8–9 experiments. *
ASI
ablation.Osmotic avoidance behavior in wild type and ASH ablation worms and osm mutants.
| Genotype | Fraction with defective osmotic avoidance |
|---|---|
| Wild type | 0.09 ± 0.03 (13) |
| 0.80 ± 0.10 (7) | |
| 0.67 ± 0.07 (7) | |
| 0.78 ± 0.03 (6) | |
| 0.60 ± 0.05 (4) |
Values are means ± S.E. (n).
*P<0.001 compared to osm mutants and ASH ablation strain. Osmotic avoidance was not significantly (P>0.05) different in osm mutants and ASH ablation worms.
Fig 2Effect of loss of ASH osmosensory neuron function on hypertonic stress induced whole animal water loss and volume recovery.
(A) Whole worm volume changes. Wild type worms and osm-9(ok1677) and osm-12(n1606) loss-of-function mutants were transferred to agar plates containing 200 mM NaCl at time 0. Values are means ± S.E. (n = 8). gpdh-1 mRNA expression (B) and whole animal glycerol levels (C) in wild type and osm-9(ok1677) and osm-12(n1606) worms. Values are means ± S.E. (n = 3). *P<0.002 and **P<0.007 compared to wild type worms. (D) Time course changes in gpdh-1 expression. Wild type worms and osm-9(ok1677) and osm-12(n1606) loss-of-function mutants were transferred to agar plates containing 200 mM NaCl at time 0. Values are means ± S.E. (n = 3–5). *P<0.01 compared to osm-9(ok1677) and osm-12(n1606) mutants.
Fig 3Hypertonic stress induced aggregation of Q35::YFP in body wall muscle cells of osm-9(ok1677) mutant worms.
(A) Survival of wild type N2, Q35::YFP and Q35;osm-9(ok1677) worms exposed to 500 or 600 mM NaCl for 24 h. Values are means ± S.E. of 6 experiments. *P<0.001 and **P<0.01 compared to wild type N2 and Q35 worms. (B) Hypertonic stress induced Q35::YFP aggregation in wild type Q35 worms and Q35;osm-9(ok1677) mutants. Values are means ± S.E. of 4 experiments with a total of 32–78 worms. The number of Q35::YFP aggregates was quantified in worms exposed to 400 mM NaCl for 24 hour or 500 mM NaCl for 1 h followed by 3 h recovery on control medium. Values are means ± S.E. (n = 3). *P<0.005 and **P<0.001 compared to wild type Q35 worms. (C) Q35::YFP volume in wild type Q35 worms and Q35;osm-9(ok1677) mutants. Worms were exposed to 500 mM NaCl for 1 h and then allowed to recover on control medium before aggregate volumes were quantified. Values are means ± S.E. (n = 20 aggregates in 5–6 worms). *P<0.0004 compared to wild type Q35 worms. (D) Time course of bleaching and fluorescence recovery of Q35::YFP aggregates in Q35;osm-9(ok1677) mutant worms. Aggregates were induced by exposing worms to 500 mM NaCl for 1 h. FRAP analysis was performed 3 h after worms were returned to 51 mM NaCl medium. Values are means ± S.E. (n = 7 aggregates in 4 worms). (E) Time course of aging induced Q35::YFP aggregation in wild type Q35 worms and Q35;osm-9(ok1677) mutants. Values are means ± S.E. (n = 3).
Fig 4Effect of RNAi induced loss of osm-9 function on let-60(ga89) induced egg hatching defects and larval arrest.
let-60(ga89) encodes a ts mutant of ras GTPase. The mutant phenotype can be induced at permissive temperatures (16°C) by exposing worms to 300 mM NaCl [14,16]). let-60(ga89) mutants were crossed with uIs60[Punc-119::yfp + Punc-119::sid-1] worms to increase the sensitivity of neurons to RNAi (46). let-60(ga89);uIs60[Punc-119::yfp + Punc-119::sid-1] worms were fed bacteria expressing scrambled (control) or osm-9 dsRNA and maintained at 16°C on agar plates containing either 51 or 300 mM NaCl. Values are means ± S.E. (n = 3–5 experiments with 100–300 eggs). *P<0.006 compared to control worms exposed to 51 mM NaCl. **P<0.005 compared to control worms exposed to 300 mM NaCl.
Fig 5Lifespan and (A) and resistance to heat shock (B), cadmium (C) and oxidative stress (D) in Median lifespan (A) was 21 days for wild type and osm-9(ok1677) worms (n = 100 worms for both groups). Values in B, C and D are means ± S.E. (n = 5). *P<0.007 and **P<0.04 compared to wild type worms.
Fig 6Protein synthesis (A) and degradation (B) in Values are means ± S.D. (n = 2 independent experiments).
Putative proteostasis genes differentially upregulated in osm-9(ok1677) worms under control conditions.
| Sequence name | Gene | Brief description and RNAi phenotypes | modENCODE ChIP-Seq Peaks | |
|---|---|---|---|---|
| C05E4.1 | Serpin serine protease inhibitor | 3.2 | ||
| C02B4.1 | Metalloproteinase | 2.9 | ||
| R11A5.7 | Peptidase | 2.8 | DAF-16 | |
| F44B9.1 | Peptidase | 2.3 | ||
| C52E4.1 | Cathepsin B-like cysteine protease | 2.1 | ||
| F41E6.6 | Protease | 2.0 | DAF-16 | |
| Y43F4A.1 | Peptidase | 1.9 | ||
| C04A11.4 | Metalloproteinase | 1.9 | SKN-1, DAF-16 | |
| ZK20.6 | Metalloproteinase | 1.9 | DAF-16 | |
| LLC1.1 | Calpain type protease; lysosome function | 1.8 | ||
| T24A11.3 | Metalloproteinase | 1.8 | SKN-1, DAF-16 | |
| ZK970.1 | Metalloproteinase | 1.8 | ||
| Y39A3CL.5 | Calpain type protease | 1.7 | DAF-16 | |
| F11A6.1 | Protease | 1.7 | SKN-1, DAF-16 | |
| Y60A3A.1 | Serine/threonine kinase; autophagy | 1.5 | ||
| K11D2.2 | Acid ceramidase; lysosome function | 2.5 | ||
| T14F9.3 | Beta-hexosaminidase; lysosome function | 1.5 | ||
| Y38F2AL.4 | Vacuolar proton ATPase subunit; lysosome function; increased protein aggregation and increased sensitivity to hypertonic stress [ | 1.5 | ||
| Y37E11AR.2 | E3 ubiquitin ligase | 3.3 | SKN-1 | |
| Y67D8C.5 | E3 ubiquitin ligase | 2.2 | DAF-16 | |
| C17H11.6 | E3 ubiquitin-protein ligase; hypersensitive to protein aggregation-induced paralysis [ | 1.6 | ||
| C35B1.1 | E2 ubiquitin-conjugating enzyme | 1.5 | ||
| Y71G12B.15 | E2 ubiquitin-conjugating enzyme | 1.4 | SKN-1, DAF-16 | |
| R10E4.2 | mRNA binding protein; regulation of translation | 2.7 | ||
| Y57A10A.30 | Translation initiation | 2.2 | DAF-16 | |
| R03G5.1 | Protein elongation; increased protein aggregation [ | 1.7 | DAF-16 | |
| C50F2.6 | Peptidyl-prolyl cis-trans isomerase (FK506-binding protein family) | 3.1 | DAF-16 | |
| ZC455.10 | Peptidyl-prolyl cis-trans isomerase (FK506-binding protein family) | 3.0 | ||
| Y18D10A.25 | Peptidyl-prolyl cis-trans isomerase (FK506-binding protein family) | 2.9 | ||
| C05C8.3 | Peptidyl-prolyl cis-trans isomerase (FK506-binding protein family) | 2.2 | DAF-16 | |
| F42G9.2 | Cyclophilin type peptidyl-prolyl cis-trans isomerase | 1.9 | DAF-16 | |
| C44H4.2 | Extracellular leucine-rich repeat protein; increased protein aggregation [ | 9.9 | ||
| ZC373.7 | Collagen; increased protein aggregation [ | 9.9 | ||
| T23F2.1 | Glycosyltransferase; increased protein aggregation [ | 5.8 | ||
| F47F6.1 | PAS domain-containing protein; increased protein aggregation [ | 5.5 | SKN-1 | |
| C42D8.5 | ACE-like protein; increased protein aggregation [ | 5.4 | ||
| ZK783.1 | Protein homologous to fibrillin; increased sensitivity to hypertonic stress [ | 4.5 | DAF-16 | |
| H04M03.4 | UDP-galactopyranose mutase; increased protein aggregation; increased sensitivity to hypertonic stress [ | 4.5 | DAF-16 | |
| W08F4.6 | Novel protein required for molting; increased protein aggregation [ | 4.4 | DAF-16 | |
| Y11D7A.9 | Unknown; increased sensitivity to hypertonic stress [ | 4.1 | ||
| W05G11.3 | Collagen; increased sensitivity to hypertonic stress [ | 3.1 | ||
| F58A4.11 | BED finger domain-containing protein; increased protein aggregation [ | 2.8 | ||
| C01F1.3 | Nucleotide-sugar metabolism; increased protein aggregation [ | 2.78 | ||
| M03F4.6 | Unknown; increased protein aggregation [ | 2.8 | DAF-16 | |
| T19B10.2 | Unknown; increased protein aggregation; increased sensitivity to hypertonic stress [ | 2.7 | DAF-16 | |
| W06F12.1 | Serine/threonine kinase; increased protein aggregation [ | 2.2 | SKN-1 | |
| Y110A2AL.8 | Patched protein homolog; increased protein aggregation [ | 2.0 | ||
| C02F5.7 | F-box motif-containing protein; resistant to protein aggregation-induced paralysis [ | 2.0 | SKN-1 | |
| W04H10.3 | NHL domain-containing protein; increased protein aggregation [ | 1.9 | SKN-1 | |
| W07E11.1 | Glutamate metabolism; increased protein aggregation [ | 1.8 | ||
| ZK1236.3 | Unknown; increased protein aggregation [ | 1.7 | ||
| ZK54.2 | Trehalose 6-phosphate synthase; increased protein aggregation; increased sensitivity to hypertonic stress [ | 1.6 | DAF-16 | |
| M110.5 | Disabled protein homolog; increased protein aggregation [ | 1.5 | DAF-16 | |
Putative proteostasis genes differentially upregulated in osm-9(ok1677) worms following a 6 h exposure to 200 mM NaCl.
| Sequence name | Gene | Brief description and RNAi phenotypes | modENCODE ChIP-Seq Peaks | |
|---|---|---|---|---|
| H19M22.3 | Metalloproteinase | 3.7 | ||
| F44B9.1 | Peptidase | 3.5 | ||
| F41E6.6 | Cathepsin-like cysteine protease | 2.0 | DAF-16 | |
| LLC1.1 | Calpain type protease; lysosome function | 1.8 | ||
| D2030.2 | Clp protease | 1.5 | DAF-16 | |
| K11D2.2 | Acid ceramidase; lysosome function | 2.3 | ||
| F27E5.1 | Acid ceramidase; lysosome function | 1.5 | ||
| Y38F2AL.4 | Vacuolar proton ATPase subunit; lysosome function; increased protein aggregation and increased sensitivity to hypertonic stress [ | 1.6 | ||
| Y37E11AR.2 | E3 ubiquitin ligase | 2.8 | SKN-1 | |
| Y18D10A.25 | Peptidyl-prolyl cis-trans isomerase (FK506-binding protein family) | 2.0 | ||
| ZC373.7 | Collagen; increased protein aggregation [ | 5.4 | ||
| C44H4.2 | Extracellular leucine-rich repeat protein; increased protein aggregation [ | 3.6 | ||
| F52B11.3 | PAN and ZP domain containing protein; increased protein aggregation [ | 2.7 | ||
| ZK783.1 | Protein homologous to fibrillin; increased sensitivity to hypertonic stress [ | 2.4 | DAF-16 | |
| C01F1.3 | Nucleotide-sugar metabolism; increased protein aggregation [ | 2.2 | ||
| C02F5.7 | F-box motif-containing protein; resistant to protein aggregation-induced paralysis [ | 1.9 | SKN-1 | |
| W07E11.1 | Glutamate metabolism; increased protein aggregation [ | 1.6 | ||